Chondrosarcoma Grade 1: Understanding Your Pathology Report

Section Editor: Bibianna Purgina MD FRCPC
October 6, 2026


Print this article

Grade 1 chondrosarcoma is a slow-growing bone cancer made of cartilage, the firm, smooth tissue that covers the ends of bones in joints. In chondrosarcoma, the cancer cells produce cartilage instead of bone. Your report may also call it low-grade chondrosarcoma.

Chondrosarcoma is one of the most common bone cancers in adults, and it usually affects people between 40 and 70 years old. The name grade 1 chondrosarcoma is used for tumors in the pelvis, the shoulder blade, the spine, and the base of the skull.

This article explains what grade 1 means, why location matters for this tumor, and what the other findings in your pathology report mean.

What does grade 1 mean?

The grade describes how abnormal the cancer cells look under the microscope. It is the most important finding in a chondrosarcoma report because it is the strongest predictor of how the tumor will behave. Chondrosarcomas are given one of three grades:

  • Grade 1. The cells look very close to normal cartilage cells. These tumors grow slowly and very rarely spread.
  • Grade 2. The tumor contains more cells, the cells look more abnormal, and some of them are dividing. These tumors are more likely than grade 1 tumors to come back after surgery, and a minority spread to other parts of the body.
  • Grade 3. The tumor is crowded with highly abnormal cells, many of which are dividing. These tumors are the most likely to spread.

Grade 1 is the lowest. Most people with a grade 1 chondrosarcoma are cured when the whole tumor is removed, and spread to other parts of the body is very rare.

Grade 1 chondrosarcoma

What is the difference between grade 1 chondrosarcoma and an atypical cartilaginous tumor?

Under the microscope, a grade 1 chondrosarcoma and an atypical cartilaginous tumor look the same. The difference is where the tumor is, because location changes how it behaves:

  • Grade 1 chondrosarcoma. This name is used for tumors in the pelvis, the shoulder blade, the spine, and the base of the skull. In these locations, the tumor is surrounded by organs, nerves, and large blood vessels, so complete removal is harder, and the tumor is more likely to come back. For this reason, it is still considered a cancer.
  • Atypical cartilaginous tumor. This name is used for the same tumor when it is in a bone of the arms, legs, hands, or feet. In these bones, the tumor rarely spreads and can usually be treated with a smaller operation or watched.

Older reports may use the name grade 1 chondrosarcoma for a tumor in an arm or leg, because the term atypical cartilaginous tumor was introduced in 2013. If your tumor is in a limb, the article on atypical cartilaginous tumor describes your situation more closely.

What causes chondrosarcoma?

For most people, no cause is found. About half of chondrosarcomas that start inside the bone carry a change in a gene called IDH1 or IDH2. This change develops in the tumor cells during a person’s lifetime. It is not inherited and cannot be passed on to children.

A few conditions raise the risk of developing chondrosarcoma:

  • Multiple enchondromas. People with many noncancerous cartilage tumors called enchondromas, a condition called Ollier disease, have a higher risk. The same is true of Maffucci syndrome, which combines enchondromas with blood vessel growths. Both are caused by an IDH change that occurs early in development and are not inherited.
  • Multiple osteochondromas. This inherited condition causes many bony outgrowths called osteochondromas, and a small proportion of them develop into chondrosarcoma. A change in the EXT1 or EXT2 gene causes it. Each child of an affected parent has a 50% chance of inheriting it.
  • Previous radiation therapy. Rarely, chondrosarcoma develops in a bone treated with radiation years earlier.

What are the symptoms of chondrosarcoma?

The most common symptom is a deep, aching pain in the affected bone. The pain often develops slowly, may be worse at night, and does not settle with rest. Some people notice a lump or swelling, and a tumor near a joint can limit movement.

Because grade 1 tumors grow slowly, symptoms often develop over months or years. A tumor in the pelvis or spine may grow quite large before anyone notices it. A tumor at the base of the skull can press on nearby nerves and cause headaches, double vision, or hearing changes.

How is the diagnosis made?

X-rays, CT, and MRI show a tumor that contains cartilage, often with small flecks of calcium. Imaging also shows whether the tumor is wearing away the bone or breaking through it.

A biopsy confirms the diagnosis. The biopsy should be done at the center that will perform the final surgery, because the track left by the needle has to be removed along with the tumor later.

Under the microscope, a grade 1 chondrosarcoma is made of cartilage cells arranged in rounded groups called lobules. The cells look only slightly abnormal, with mild nuclear atypia, and dividing cells, called mitoses, are rare or absent.

A grade 1 chondrosarcoma can look almost identical to an enchondroma, a noncancerous cartilage tumor. The key difference is that the chondrosarcoma grows into the spaces of the surrounding bone and surrounds the existing bone. Clinicians use imaging together with the microscope to make this distinction.

Different parts of a chondrosarcoma can look different, so the grade on a biopsy is sometimes revised after the whole tumor has been removed and examined.

Molecular testing

Testing for an IDH1 or IDH2 change may be done on the tumor. Finding one supports the diagnosis and helps separate chondrosarcoma from chondroblastic osteosarcoma, a different bone cancer that also contains cartilage but is treated with chemotherapy.

An IDH change does not separate a grade 1 chondrosarcoma from an enchondroma, because enchondromas carry the same change.

Tumor extension

Grade 1 chondrosarcoma usually starts inside the bone. Your report may describe whether the tumor has broken through the outer shell of the bone into the surrounding muscle or other soft tissue. This is called extraosseous extension.

The report may also note whether the tumor has grown into a nearby joint or an adjacent bone. In the spine and pelvis, which are made of several connected bones, spread from one bone to another raises the stage.

Margins

A margin is the edge of tissue cut by the surgeon. For chondrosarcoma, margins are especially important because surgery is the main treatment, and tumor left behind is the main reason the cancer comes back.

  • Negative margin. No cancer cells are seen at the cut edge. The report may give the distance between the tumor and the closest margin.
  • Positive margin. Cancer cells reach the cut edge, and some tumor may remain. This raises the chance the cancer will come back in the same place.

Your report will usually list several margins, including the cut ends of the bone, the surrounding soft tissue, and any large blood vessels or nerves that were removed.

Stage

Bone cancers are staged using the TNM system from the American Joint Committee on Cancer (AJCC), 8th edition. The tumor stage, called pT, depends on which bone is involved:

  • Arms, legs, trunk, skull, and face. The stage depends mainly on size. A tumor 8 cm or smaller is pT1, and a tumor larger than 8 cm is pT2. Separate tumor deposits within the same bone are classified as pT3.
  • Spine and pelvis. These bones have their own staging rules, based on how many bone segments are involved and whether the tumor extends beyond the bone.
  • Lymph nodes. Chondrosarcoma rarely spreads to lymph nodes, so surgeons usually do not remove them. When no nodes are examined, the report may say the nodal stage was not assigned.

When chondrosarcoma spreads, it usually travels through the bloodstream to the lungs, which is why a chest CT scan is part of the assessment.

What is the prognosis?

The outlook for grade 1 chondrosarcoma is very good. Roughly 85% to 95% of people are alive five years after diagnosis, and spread to other parts of the body is very rare.

The main concern is the tumor coming back in the same place, which is more likely in the pelvis, spine, and skull base than in the limbs. When a grade 1 chondrosarcoma comes back, about 1 in 10 recurrences are a higher-grade tumor. This is why complete removal at the first operation matters so much.

Chondrosarcoma can come back many years after surgery, sometimes more than 10 years later. These figures describe groups of people and cannot predict what will happen to one person.

What happens after the diagnosis?

A team at a center that regularly treats bone sarcomas manages chondrosarcoma.

  • Surgery. The main treatment is removing the tumor with a rim of normal tissue. Part of the bone may be replaced with an implant or graft. Scraping out the tumor is often used for atypical cartilaginous tumors in the limbs. It is usually not recommended for grade 1 chondrosarcoma in the pelvis or spine, because it is more likely to leave tumor behind.
  • Radiation therapy. Chondrosarcoma does not respond well to standard radiation. High-dose or proton radiation is commonly used for tumors at the base of the skull, where complete removal is rarely possible, and for other tumors that cannot be removed completely.
  • Chemotherapy. Standard chemotherapy works poorly for chondrosarcoma and is not routinely used.
  • Follow-up. Regular imaging of the original site and of the chest continues for many years.

Questions to ask your doctor

  • Is my tumor called a grade 1 chondrosarcoma or an atypical cartilaginous tumor, and why?
  • Was the grade confirmed after the whole tumor was removed?
  • Was the whole tumor removed, and were all the margins negative?
  • Did the tumor grow outside the bone?
  • Will I need radiation therapy, and would proton therapy be an option?
  • What is the chance the tumor will come back?
  • How often will I need follow-up imaging, and for how many years?

Related articles on MyPathologyReport.com

A+ A A-
Was this article helpful?